Bako Diagnostics
Daniel Holsinger has over 25 years of work experience in the healthcare industry. Daniel currently serves as the Vice President of Revenue Cycle at Bako Diagnostics. Prior to this, they worked at Adaptive Biotechnologies Corp as the Director of Reimbursement. From 2009 to 2019, they held the position of Director of Reimbursement Services at Genova Diagnostics. Before that, they worked at LabCorp in various roles including Divisional A/R Director, Billing Manager, Manager of Patient Customer Service, Training Supervisor, and Patient Billing Representative.
Daniel Holsinger completed their Bachelor of Arts degree in Political Science from the University of North Carolina at Greensboro, where they studied from 1991 to 1996. Later, from 2004 to 2006, they pursued their Master in Business Administration (MBA) in Healthcare Operations from The University of Dallas.
This person is not in any offices
Bako Diagnostics
Bako Diagnostics is a provider of diagnostic and therapeutic services with a unique focus on pathology of the lower extremity. Bako’s comprehensive testing menu includes ENFD Analysis, Mass Spectrometry, for rapid identification of bacteria from culture specimens, and Molecular Genetics for the detection of micro-organisms and as a diagnostic aid in certain pathologic diagnoses. Bako’s in-network services are available through its more than 200 million covered lives, including all five national health plans and fully compliant patient-friendly billing policies. Over the past nine years, Bako has evolved into one of the podiatric profession’s principal sources of educational sponsorship. Bako Diagnostics, your professional partner for disease diagnostics and management! For more information, call us at 855-422-5628 or visit bakodx.com.